Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Chiara Mazzarelli Stefano Fagiuoli Raffaella Lionetti Marzia Montalbano Marco Biolato Ubaldo Visco-Comandini Ilaria Lenci |
| Publication date | November 29, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |